LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.0056667
 46.95 84.90 1622 4952 0.3275 0.6535
MN20160318_Q02
C11
MCF 10A-H2B-mCherry Trametinib
0.0056667
 46.95 84.90 1738 4952 0.3509 0.6730
MN20160318_Q02
F12
MCF 10A-H2B-mCherry Trametinib
0.0056667
 46.95 84.90 1881 4952 0.3798 0.6957
MN20160318_Q02
F12
MCF 10A-H2B-mCherry Trametinib
0.0056667
 48.65 84.90 1550 5328 0.2909 0.6264
MN20160318_Q02
C11
MCF 10A-H2B-mCherry Trametinib
0.0056667
 48.65 84.90 1592 5328 0.2988 0.6337
MN20160318_Q02
C11
MCF 10A-H2B-mCherry Trametinib
0.0056667
 48.65 84.90 1749 5328 0.3282 0.6596
MN20160318_Q02
F12
MCF 10A-H2B-mCherry Trametinib
0.0056667
 48.65 84.90 1874 5328 0.3517 0.6789
MN20160318_Q02
F12
MCF 10A-H2B-mCherry Trametinib
0.0056667
 50.36 84.90 1712 5651 0.3030 0.6421
MN20160318_Q02
C11
MCF 10A-H2B-mCherry Trametinib
0.0056667
 50.36 84.90 1751 5651 0.3099 0.6482
MN20160318_Q02
C11
MCF 10A-H2B-mCherry Trametinib
0.0056667
 50.36 84.90 1919 5651 0.3396 0.6733
MN20160318_Q02
F12
MCF 10A-H2B-mCherry Trametinib
0.0056667
 50.36 84.90 2046 5651 0.3621 0.6911
MN20160318_Q02
F12
MCF 10A-H2B-mCherry Trametinib
0.0056667
 52.06 84.90 1717 5990 0.2866 0.6318
MN20160318_Q02
C11
MCF 10A-H2B-mCherry Trametinib
0.0056667
 52.06 84.90 1756 5990 0.2931 0.6377
MN20160318_Q02
C11
MCF 10A-H2B-mCherry Trametinib
0.0056667
 52.06 84.90 1985 5990 0.3313 0.6708
MN20160318_Q02
F12
MCF 10A-H2B-mCherry Trametinib
0.0056667
 52.06 84.90 2109 5990 0.3520 0.6873
MN20160318_Q02
F12
MCF 10A-H2B-mCherry Trametinib
0.0056667
 53.77 84.90 1892 6252 0.3026 0.6494
MN20160318_Q02
C11
MCF 10A-H2B-mCherry Trametinib
0.0056667
 53.77 84.90 1934 6252 0.3093 0.6553
MN20160318_Q02
C11
MCF 10A-H2B-mCherry Trametinib
0.0056667
 53.77 84.90 2012 6252 0.3218 0.6659
MN20160318_Q02
F12
MCF 10A-H2B-mCherry Trametinib
0.0056667
 53.77 84.90 2123 6252 0.3395 0.6803
MN20160318_Q02
F12
MCF 10A-H2B-mCherry Trametinib
0.0056667
 55.48 84.90 1886 6567 0.2872 0.6393
MN20160318_Q02
C11
MCF 10A-H2B-mCherry Trametinib
0.0056667
 55.48 84.90 1926 6567 0.2933 0.6448
MN20160318_Q02
C11
MCF 10A-H2B-mCherry Trametinib
0.0056667
 55.48 84.90 2175 6567 0.3312 0.6770
MN20160318_Q02
F12
MCF 10A-H2B-mCherry Trametinib
0.0056667
 55.48 84.90 2276 6567 0.3465 0.6891
MN20160318_Q02
F12
MCF 10A-H2B-mCherry Trametinib
0.0056667
 57.18 84.90 2009 6963 0.2885 0.6448
MN20160318_Q02
C11
MCF 10A-H2B-mCherry Trametinib
0.0056667
 57.18 84.90 2044 6963 0.2935 0.6493
MN20160318_Q02
C11